Nemáte dosť času na prečítanie celého článku? Vypočujte si zhrnutie za 2 minúty.
Many pharmaceutical companies believe their supply chains are functioning well because operations appear stable on the surface.
Factories are producing. Warehouses remain stocked. Distribution networks continue supplying hospitals and pharmacies. From an operational distance, everything appears under control.
Yet inside many organizations, supply chain leaders know a different reality is emerging.
Forecast numbers change every month. Production plans constantly adjust. Inventory levels grow unevenly across markets. Critical medicines face shortages while slow-moving products accumulate in warehouses.
These contradictions often signal something deeper.
The company’s Sales and Operations Planning discipline, commonly known as S&OP, is quietly breaking down.
What S&OP is supposed to achieve
In principle, S&OP exists to answer one central question:
How do we align what the market wants with what our manufacturing network can realistically deliver?
To achieve that alignment, S&OP connects three planning horizons:
- Commercial demand forecasts
- Manufacturing capacity and production planning
- Distribution and inventory management
In many industries this process is already complex. In pharmaceutical manufacturing it becomes even more demanding.
Production cycles can take several months. Batch validation must meet strict regulatory requirements. Shelf life constraints limit how long medicines can be stored. Products may also be tied to specific manufacturing sites due to regulatory approvals.
This means planning errors cannot be corrected quickly.
When alignment breaks, the consequences appear slowly but become difficult to reverse.
The moment discipline begins to erode
S&OP rarely collapses suddenly. The breakdown usually begins with small adjustments that seem harmless at first.
A commercial team increases the forecast for a product expected to grow rapidly. Manufacturing teams adjust production plans to support the new demand. Distribution networks expand inventory buffers to prevent shortages.
Individually these decisions appear logical.
But when each function adjusts independently, the overall balance begins to drift.
Production schedules no longer reflect true demand. Inventory becomes uneven across markets. Forecast changes ripple through manufacturing campaigns.
Over time the organization begins reacting to supply problems rather than planning ahead.
A familiar scenario inside pharmaceutical companies
Consider a European pharmaceutical manufacturer launching several new products while expanding its manufacturing footprint.
Commercial teams expect strong growth and increase demand projections. Plants attempt to respond by allocating production capacity to the new portfolio.
At first the system appears flexible enough to handle the expansion.
But after several planning cycles, inconsistencies begin appearing across the network.
Certain markets experience stock-outs because manufacturing campaigns cannot adapt quickly enough. Other regions accumulate excess inventory of products whose demand never materialized as expected.
The company eventually discovers that the issue is not manufacturing capacity or market demand.
The real problem is that planning decisions across the organization are no longer synchronized.
The structural causes behind S&OP breakdown
When S&OP discipline weakens, the underlying causes usually fall into four operational categories.
Demand inflation
Commercial teams often overestimate demand in order to secure manufacturing allocation. Forecasts gradually drift away from real market consumption.
Production rigidity
Pharmaceutical manufacturing runs on long campaign cycles. Once production plans are fixed, adjusting them quickly becomes difficult.
Data fragmentation
Different teams work with different planning assumptions. Forecast updates do not always reach manufacturing teams at the right time.
Leadership hesitation
Most importantly, no single leader takes responsibility for resolving conflicts between commercial priorities and operational realities.
These forces accumulate quietly until supply chain stability begins to deteriorate.
Why technology rarely fixes the problem
Many organizations respond to S&OP instability by investing in new planning tools.
Advanced forecasting software, data integration platforms and predictive analytics systems promise better visibility and faster decision-making.
While these technologies improve data quality, they rarely solve the underlying problem.
S&OP is ultimately a governance process, not a technology platform.
It requires regular leadership decisions about production priorities, inventory strategies and demand assumptions. Without disciplined leadership engagement, better data only makes conflicting decisions appear faster.
The operational signals that S&OP is failing
Experienced supply chain leaders often recognize the warning signs early. Several indicators usually appear before major supply disruptions occur.
Forecast revisions become more frequent from one planning cycle to the next. Manufacturing teams begin adjusting production schedules outside the formal planning process. Emergency shipments increase as companies try to correct shortages. Meanwhile inventory levels grow unevenly across product portfolios.
When these signals appear together, it usually means the organization has lost planning discipline.
Rebuilding that discipline requires more than process adjustments.
It requires restoring operational leadership.
Where interim leadership stabilizes supply chains
When S&OP governance begins to collapse, companies sometimes need immediate operational leadership to restore coordination across functions.
Interim executives often step into roles such as Interim Supply Chain Director, Interim COO or Interim Operations Leader.
Their mandate is not simply improving forecasts.
Instead, they focus on rebuilding the decision structure that keeps supply chains aligned.
This includes restoring the cadence of executive planning meetings, enforcing accountability for demand assumptions, and aligning manufacturing priorities with real market demand.
Pretože dočasní vedúci operate directly within the organization, they can resolve conflicts between commercial, manufacturing and supply chain teams quickly.
In many situations, restoring that leadership discipline stabilizes the entire planning process within a few months.
Why S&OP discipline matters more than ever
Pharmaceutical supply chains are becoming more complex each year.
Manufacturing networks span multiple regions. Product portfolios expand rapidly. Governments and regulators increasingly demand supply reliability for critical medicines.
These pressures make planning discipline far more important than it was a decade ago.
Factories may continue producing and warehouses may remain full, but without strong coordination between demand and supply, stability becomes fragile.
Rebuilding S&OP discipline is therefore not only a supply chain challenge.
It is a leadership challenge that sits at the center of pharmaceutical operations.
